Is prostatic adenocarcinoma detectable by urine cytology—A multicenter retrospective review
The Prostate · 2025
DOI: 10.1002/pros.24805 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Prostate, 2025. Verfasst von Cheuk-Yin Tang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Adenocarcinoma, Prostate-Specific Antigen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Urine cytology is robust for the diagnosis of urothelial lesions, but data on the detection rates of prostatic adenocarcinoma in urine cytology is limited. In this study, a multicenter review was performed to define the clinical role of urine cytology in diagnosis of prostatic adenocarcinoma.
Methods
Cytologic diagnoses of lower tract urine cytology specimens with histology‐proven prostatic adenocarcinoma from three institutions, from a period of over two decades, were reviewed. Clinicopathological parameters—tumor grade, stage, histologic features, and preanalytical factors—prostate‐specific antigen (PSA) level and lesion size, were retrieved and compared with cytologic diagnoses.
Results
In total, 2115 urine cytology specimens from 1119 patients were retrieved. The atypia (or above/C3+) and suspicious (or above/C4+) rates were 19.48% and 3.36%. Bilobar and extracapsular involvement, lymphovascular invasion, Gleason score, and International Society of Urological Pathology grade were associated with a positive urine diagnosis ( p < 0.05). The atypia (C3+) and suspicious (C4+) rates of urine cytology in patients with a PSA level of ≤4.0 ng/mL was paradoxically higher ( p < 0.01), but PSA levels correlated positively with urine diagnosis at higher cutoffs (>10, >20, >50, >100 ng/mL). All these factors remained significant on multivariate analysis ( p < 0.05), including a negative correlation with low‐PSA (≤4.0 ng/mL, p = 0.001) and positive correlation with high‐PSA (>20 ng/mL, p = 0.020). Lesion size and multifocality were not associated with urine cytology diagnosis ( p > 0.05).
Conclusion
Urine cytology showed low sensitivity in detection of prostatic adenocarcinoma. Detection rates were largely positively correlated with PSA levels but not for lesion size nor multifocality, limiting its clinical utility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong.
- Department of Pathology, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong.
- Department of Surgery, S.H. Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, Hong Kong.
- Johns Hopkins Medical Institutions, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Deparment of Pathology, North District Hospital, Hong Kong, Hong Kong.
ORCID-Profile: Joshua J X Li
Zitieren
APA
Tang, C. Y., Li, J. J. X., Leung, K. L., Ma, H. Y., Ng, J. K. M., Yan, R. T. L., Teoh, J. Y., VandenBussche, C. J., & Tse, G. M. (2025). Is prostatic adenocarcinoma detectable by urine cytology—A multicenter retrospective review. The Prostate. https://doi.org/10.1002/pros.24805
Vancouver
Tang CY, Li JJX, Leung KL, Ma HY, Ng JKM, Yan RTL, et al. Is prostatic adenocarcinoma detectable by urine cytology—A multicenter retrospective review. The Prostate. 2025. doi:10.1002/pros.24805
BibTeX
@article{Tang2025,
author = {Tang, Cheuk-Yin and Li, Joshua J X and Leung, Ka Long and Ma, Hei Yuet and Ng, Joanna K M and Yan, Ryan T L and Teoh, Jeremy Y and VandenBussche, Christopher J and Tse, Gary M},
title = {Is prostatic adenocarcinoma detectable by urine cytology—A multicenter retrospective review},
journal = {The Prostate},
year = {2025},
doi = {10.1002/pros.24805}
}
EUVIMED